This site is intended for healthcare professionals registered within the Republic of Ireland. If you are a member of the public, please click here.
We offer content that is individually tailored to your field of expertise and your needs. To make this possible, we ensure technically that the content that interests you and your area of expertise can be evaluated. For this we need your approval in advance: I agree that www.hcp.novartis.ie evaluates my user behaviour, as described in more detail here. I can revoke this consent at any time with effect for the future.
Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.